Source: Annual Congress 2001 - Exposure to allergens and chemicals: clincial and mechanistical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Anees, V. Huggins, I. Pavord, A. S. Robertson, S. Burge (Birmingham, Leicester, United Kingdom). Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Eur Respir J 2001; 16: Suppl. 31, 1882

Member's Comments

No comment yet.

Related content which might interest you: Different level of GSNO(S-nitrosoglutathione) between eosinophilic bronchitits and asthma Source: Annual Congress 2009 - Inflammation and airways Year: 2009 Comparison between airway response to high versus low molecular weight agents in occupational asthma Source: Annual Congress 2010 - Occupational asthma Year: 2010 Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Comparative airway response to high- versus low-molecular weight agents in occupational asthma Source: Eur Respir J 2009; 33: 734-739 Year: 2009 Occupational asthma and extrinsic allergic alveolitis: old conditions with many new causes Source: International Congress 2015 – Emerging occupational and environmental lung hazards: from asthma to interstitial disease Year: 2015 Definitions and types of work-related asthma: a nosological approach Source: Eur Respir J 2003; 21: 706-712 Year: 2003 Occupational asthma induced by exposure to high and low molecular weight agents. Similarities and differences Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 New-onset work-related airway symptoms in workers exposed to high molecular weight (HMW) agents are predicted by clinical markers of airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 509s Year: 2001 Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Rate of FEV1 decline in workers with eosinophilic and non-eosinophilic occupational asthma Source: Eur Respir J 2007; 30: Suppl. 51, 155s Year: 2007 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Allergic and nonallergic factors in severe asthma Source: Eur Respir Mon 2011; 51: 107-119 Year: 2011 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005